Chronic Condition Management

Health care fraud, new payment models and AI are all in play in evolution of accountable care

Access, AI and accountable care are part of now and the future, CMS leaders say.

The multicenter study is evaluating whether localized cryotherapy, guided by AI-enabled imaging, can stabilize non-obstructive high-risk plaques before they trigger a heart attack.

Patient demand is high, but distinctions are fuzzy about compounded GLP-1s. Primary care physicians can help

For better health at a cheaper cost, the nation needs more investment, access and doctors in primary care.

When patients ask about compounded semaglutide or tirzepatide, practices need a repeatable way to document, triage and react

A dementia expert explains practical screening steps, early warning signs and how to approach the conversation once a diagnosis is made

AMGA, lawmakers lead charge against beneficiary pay for chronic care management.

New YouGov data rank what patients consider before agreeing to a treatment.

The direct-to-employer model gets GLP-1s to patients without a pharmacy benefit manager or prior authorization, but the discounted price can disappear when a patient leaves the job.

Two family doctors explain a new NASEM report recommending community-clinical partnerships

What primary care physicians should know about developing science that moves beyond skin substitutes.

Tandem Diabetes Care expands its Control-IQ+ automated insulin delivery system to work with Abbott's newest 15-day continuous glucose monitor across the United Kingdom, Switzerland, Sweden, Finland and Italy, with Belgium, the Netherlands and Germany slated to follow later this year.

Physicians are loading protected health information into consumer AI tools. Here’s how to avoid risk of HIPAA violations

Because compiling and feeding masses of data to Medicare takes time away from treating patients.

A new national survey finds just 71% of adults under 30 have a primary care physician, and fewer than half of those saw one in the past year.

Primary care is a team sport, but some of the most important players are outside the physician’s office.

Could a simple blood test transform how we diagnose Alzheimer's disease? A primer on what primary care physicians should know about blood-based biomarkers right now

Andel is one of a growing number of companies selling brand-name drugs straight to employers, bypassing pharmacy benefit managers and insurers. Medical Economics sat down with founder and CEO Jay Bregman to understand the model and what physicians should keep in mind.

Two new federal programs are opening Medicare and Medicaid coverage for GLP-1 obesity drugs, and Tracy Zvenyach, Ph.D., M.S., RN, of the Obesity Action Coalition explains what it means for primary care physicians and their patients.

Primary care is a team sport, but some of the most important players are outside the physician’s office.

What works well when health care partners with community groups? National Academy of Medicine offers answers for Medicare.

An Obesity Action Coalition leader discusses latest developments in treatment of obesity as a chronic disease.

Medication adherence is a persistent challenge in healthcare. Prior auths are making it worse. Can CMS fix the problem?

Rising costs are forcing employers into tough decisions about coverage — and the numbers may shift again by 2027.